Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Small-Cap Value Fund, Inc.

T. Rowe Price Small-Cap Value Fund, Inc. (PASVX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price Small-Cap Value Fund, Inc. (CIK 834798) · SEC series S000002121

Share classes and tickers: PASVX (C000005511), PRSVX (C000005510), PRVIX (C000159683), TRZVX (C000219318)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,724 with, 33 against, 0 abstentions (not counted as with management); 11 split votes are in neither count. Shareholder proposals: 4 FOR, 7 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)91.8%2,63793.7%208,710
Backed environmental and social shareholder proposals at US companiesn/a12.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 45 items (2.1% of the 2,173 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
AGCO Corporation2026-04-23Shareholder Stockholder proposal regarding giving stockholders an ability to call for a special stockholder meeting, if properly presented at the meeting.ForAGAINST — 11 of 11 T. Rowe Price fundsAgainstFailed (calculated), 48.7% support
AGCO Corporation2026-04-23Election of Directors: Niels PorksenAgainstFOR — 11 of 11 T. Rowe Price fundsAgainstPassed (calculated), 95.2% support
SmartStop Self Storage REIT, Inc.2026-06-23The election of six directors, each to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualifies: David J. MuellerWithholdFOR — 9 of 9 T. Rowe Price fundsAgainstElected, 92.1% support
SmartStop Self Storage REIT, Inc.2026-06-23The election of six directors, each to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualifies: Harold "Skip" PerryWithholdFOR — 9 of 9 T. Rowe Price fundsAgainstElected, 88.9% support
SmartStop Self Storage REIT, Inc.2026-06-23The election of six directors, each to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualifies: Timothy S. MorrisWithholdFOR — 9 of 9 T. Rowe Price fundsAgainstElected, 92.9% support
Advance Auto Parts, Inc.2026-05-20Election of the ten directors listed below: Eugene I. Lee, Jr.ForAGAINST — 5 of 5 T. Rowe Price fundsForElected, 84.2% support
Fastly, Inc.2026-06-03To elect each of the Board's three nominees for director named in the accompanying proxy statement, to serve as a Class I member of the Board of Directors until the 2029 annual meeting of stockholders: Aida AlvarezWithholdFOR — 5 of 5 T. Rowe Price fundsAgainstPassed (calculated), 65.1% support
Quaker Houghton2026-05-13Election of Directors: Nandita BakhshiForAGAINST — 5 of 5 T. Rowe Price fundsFor—
Stoke Therapeutics, Inc.2026-06-032 wordings Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: G. Clare Kahn, Ph.D.WithholdFOR — 8 of 9 T. Rowe Price fundsAgainstPassed (calculated), 99.4% support
Stoke Therapeutics, Inc.2026-06-03To approve, on an advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 10 of 12 T. Rowe Price fundsAgainstPassed (calculated), 72.9% support
Valmont Industries, Inc.2026-04-27Election of Directors: Richard A. LanohaForWITHHOLD — 4 of 4 T. Rowe Price fundsFor—
TTM Technologies, Inc.2026-05-07To elect Julie S. England, Philip G. Franklin and Edwin Roks as class II directors: Philip G. FranklinForAGAINST — 4 of 4 T. Rowe Price fundsFor—
WSFS Financial Corporation2026-05-14ELECTION OF DIRECTORS: Eleuthere I. du PontForWITHHOLD — 4 of 4 T. Rowe Price fundsForPassed (calculated), 96.4% support
United Parks & Resorts Inc.2025-09-03To grant the Board of Directors of United Parks & Resorts Inc. (the "Company") the authority to approve and implement additional repurchases of shares of the Company's common stock, subject to the qualification that the Company will not repurchase additional shares if Hill Path Capital LP's ("Hill PForAGAINST — 4 of 4 T. Rowe Price fundsFor—
Primerica, Inc.2026-05-21To elect the following directors: Cynthia N. DayAgainstFOR — 3 of 3 T. Rowe Price fundsAgainstElected, 91.9% support
Zurn Elkay Water Solutions Corporation2026-04-30Election of Directors: Thomas D. ChristopoulForWITHHOLD — 3 of 3 T. Rowe Price fundsForPassed (calculated), 94.9% support
Spire Inc.2026-01-29Election of Directors: Rob L. JonesForWITHHOLD — 3 of 3 T. Rowe Price fundsForPassed (calculated), 98.4% support
Spire Inc.2026-01-29Election of Directors: Sheri S. CookForWITHHOLD — 3 of 3 T. Rowe Price fundsForPassed (calculated), 99.2% support
Spire Inc.2026-01-29Election of Directors: Vinny J. FerrariForWITHHOLD — 3 of 3 T. Rowe Price fundsForPassed (calculated), 98.7% support
TeraWulf Inc.2026-06-09Election of directors: Catherine MotzForWITHHOLD — 3 of 3 T. Rowe Price fundsForElected, 95.0% support
TeraWulf Inc.2026-06-09Election of directors: Michael BucellaForWITHHOLD — 3 of 3 T. Rowe Price fundsForElected, 96.6% support
TeraWulf Inc.2026-06-09Election of directors: Steven PincusForWITHHOLD — 3 of 3 T. Rowe Price fundsForElected, 92.2% support
TeraWulf Inc.2026-06-09The approval, on a non-binding, advisory basis, of the compensation of our named executive officers ("Say-on-Pay"); andForAGAINST — 5 of 6 T. Rowe Price fundsForApproved, 66.1% support
Marriott Vacations Worldwide Corporation2026-05-15Approval of the Second Amended and Restated Marriott Vacations Worldwide Corporation 2020 Equity Incentive Plan.ForAGAINST — 3 of 3 T. Rowe Price fundsForApproved, 69.0% support
Vishay Intertechnology, Inc.2026-05-18Election of Directors Nominees for 3-year terms: John MalvisiForWITHHOLD — 3 of 3 T. Rowe Price fundsFor—
Show all 45
Items 26 to 45.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
BankUnited, Inc.2026-05-21To approve the BankUnited, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan.ForAGAINST — 3 of 3 T. Rowe Price fundsForPassed (calculated), 60.2% support
Helios Technologies, Inc.2026-06-15To elect three Directors, currently serving on our Board, to serve until the Annual Meeting in 2029, and one director to serve until the Annual Meeting in 2027, whom shall serve until successors are elected and qualified or until an earlier resignation, removal from office or death: Laura Dempsey BrAgainstFOR — 3 of 3 T. Rowe Price fundsAgainstPassed (calculated), 94.4% support
Helios Technologies, Inc.2026-06-15To elect three directors, currently serving on our Board, to serve until the Annual Meeting in 2029, and one director to serve until the Annual Meeting in 2027, whom shall serve until successors are elected and qualified or until an earlier resignation, removal from office or death: Cary ChenandaAgainstFOR — 3 of 3 T. Rowe Price fundsAgainstElected, 95.3% support
Helios Technologies, Inc.2026-06-15To elect three directors, currently serving on our Board, to serve until the Annual Meeting in 2029, and one director to serve until the Annual Meeting in 2027, whom shall serve until successors are elected and qualified or until an earlier resignation, removal from office or death: Ian WalshAgainstFOR — 3 of 3 T. Rowe Price fundsAgainstElected, 96.1% support
Agios Pharmaceuticals, Inc.2026-06-18To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Cynthia SmithWithholdFOR — 5 of 6 T. Rowe Price fundsAgainstPassed (calculated), 68.3% support
Agios Pharmaceuticals, Inc.2026-06-18To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Rahul Ballal, Ph.D.WithholdFOR — 5 of 6 T. Rowe Price fundsAgainstPassed (calculated), 87.1% support
BellRing Brands, Inc.2026-01-28Election of Directors: Robert V. VitaleWithholdFOR — 3 of 3 T. Rowe Price fundsAgainstElected, 73.9% support
Safehold Inc.2026-05-14Approval of proposed amendment to Amended and Restated 2009 Long Term Incentive PlanForAGAINST — 3 of 3 T. Rowe Price fundsForApproved, 90.5% support
TowneBank2026-05-20To elect 10 directors: Douglas D. EllisWithholdFOR — 3 of 3 T. Rowe Price fundsAgainst—
TowneBank2026-05-20To elect 10 directors: Jeffrey F. BensonWithholdFOR — 3 of 3 T. Rowe Price fundsAgainst—
Cipher Digital Inc.2026-06-02Approval, on a non-binding advisory basis, of the compensation of our named executive officers.ForAGAINST — 4 of 5 T. Rowe Price fundsForApproved, 83.5% support
Pinnacle Financial Partners, Inc.2025-11-06A proposal to approve and adopt the Agreement and Plan of Merger by and among Pinnacle Financial Partners, Inc. ("Pinnacle"), Synovus Financial Corp. ("Synovus") and Steel Newco Inc. ("Newco"), dated as of July 24, 2025 (as amended from time to time, the "merger agreement"), pursuant to which, on thForAGAINST — 6 of 9 T. Rowe Price fundsFor—
Dianthus Therapeutics, Inc.2026-05-21To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorgeWithholdFOR — 9 of 16 T. Rowe Price fundsAgainstPassed (calculated), 80.6% support
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. BancroftWithholdFOR — 8 of 15 T. Rowe Price fundsAgainstElected, 78.7% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: David Schenkein, M.D.WithholdFOR — 8 of 15 T. Rowe Price fundsAgainstElected, 73.5% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: Jennifer CookWithholdFOR — 8 of 15 T. Rowe Price fundsAgainstElected, 60.9% support
Sarepta Therapeutics, Inc.2026-06-04To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Michael ChambersForAGAINST — 3 of 4 T. Rowe Price fundsForElected, 97.4% support
Ponce Financial Group, Inc.2026-06-11Approval, on an advisory and non-binding basis, of the compensation of the named executive officers.ForAGAINST — 3 of 4 T. Rowe Price fundsForApproved, 65.4% support
Impinj, Inc.2026-05-28Election of Directors: Steve SanghiAgainstFOR — 7 of 13 T. Rowe Price fundsAgainstElected, 68.1% support
NovoCure Limited2026-06-03The approval of our amended and restated 2024 Omnibus Incentive Plan.ForAGAINST — 2 of 3 T. Rowe Price fundsForApproved, 50.3% support

Download all 45 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 87.8% of this fund’s 2,757 such votes could be given a sector; the other 336 (12.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance571132.3%
Consumer Discretionary41841.0%
Industrials39761.5%
Health Care32210.3%
Technology19110.5%
Real Estate18100.0%
Energy15300.0%
Utilities10411.0%
Consumer Staples4800.0%
Basic Materials1600.0%
Miscellaneous1000.0%
Telecommunications1000.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,91213
Audit-related3083
Say-on-Pay2984
Compensation1042
Corporate Governance959
Capital Structure360
Extraordinary Transactions181
Other150
Shareholder Rights and Defenses60
Other Social Issues20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Pinnacle Financial Partners, Inc.May 21, 2026$217M190
Columbia Banking System, Inc.May 14, 2026$181M140
Viavi Solutions Inc.November 12, 2025$178M130
Pinnacle Financial Partners, Inc.November 6, 2025$173M30
Columbia Banking System, Inc.July 21, 2025$155M20
Matador Resources CompanyJune 11, 2026$105M50
Permian Resources CorporationMay 19, 2026$104M140
PBF Energy Inc.April 28, 2026$93M140

Notable votes against management

MeetingCompanyProposalFundMgmt
May 19, 2026Live Oak Bancshares, Inc.Election of Directors: Tonya W. BradfordForAgainst
May 19, 2026Live Oak Bancshares, Inc.Election of Directors: David G. LuchtForAgainst
May 20, 2026Reliance, Inc.To consider a stockholder proposal requiring any director who fails to receive a majority vote to leave the board of directors within nine months. Shareholder proposalAgainstFor
May 14, 2026OGE Energy Corp.Shareholder Proposal Regarding Simple Majority Vote. Shareholder proposalForAgainst
May 21, 2026FS Bancorp, Inc.Advisory (non-binding) approval of the compensation of our named executive officers as disclosed in the proxy statement.ForAgainst
May 21, 2026FS Bancorp, Inc.Adoption of the FS Bancorp, Inc. 2026 Equity Incentive Plan.ForAgainst
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalAgainstFor
December 15, 2025UniFirst CorporationTo elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler Shareholder proposalForAgainst
December 15, 2025UniFirst CorporationTo elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti Shareholder proposalForAgainst
May 14, 2026Flowserve CorporationShareholder Proposal requesting an annual advisory shareholder vote regarding Flowserve stock repurchases. Shareholder proposalAgainstFor
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
May 14, 2026Wyndham Hotels & Resorts, Inc.To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

2,795 ballot items at 319 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Small-Cap Value Fund, Inc. (PASVX) voted at 319 shareholder meetings of 312 companies, on 2,795 ballot items in all. Where management made a recommendation, the fund followed it on 98.8% of the items and voted against it 33 times. Its most frequent area of disagreement was director elections (13 of its votes against management). It voted on 11 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (91.8% against 93.7%). It voted differently from most T. Rowe Price funds on 45 items. 2 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.